Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

NCT01611857 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumour
Gastroesophageal Cancer

Interventions

DRUG: Tivantinib
DRUG: FOLFOX

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]